In the fields of cardiovascular stents, orthopedic implants, and surgical instruments, the biocompatibility and antibacterial properties of medical device surfaces directly impact patient recovery and safety. Anhui Aiyota has developed aminosilane and epoxysilane coupling agents, providing a reliable material basis for functionalized coatings on medical device surfaces.

Silane coupling agents can form 100-500 nm thick organic-inorganic hybrid films on substrates such as metals, ceramics, and polymers. Through chemical bonding, they enhance coating adhesion and provide active functional groups such as amino and epoxy groups for grafting bioactive molecules such as heparin, chitosan, and antimicrobial peptides. Clinical trials have shown that silane-treated vascular stents exhibit a 60% increase in endothelial cell adhesion and an 80% reduction in platelet adhesion, significantly reducing the risk of thrombosis.

Aiyota's medical-grade silanes have passed ISO10993 biocompatibility testing, with metal impurity content below 1 ppm and endotoxin levels meeting pharmacopoeia requirements. Our products have been applied in areas such as cardiac stent coatings, orthopedic implant surface treatments, and catheter lubrication coatings, and have obtained NMPA and FDA medical device registration certifications. The company provides GMP-level product manufacturing, surface grafting process development, and biological performance evaluation services to help medical device companies develop high-end functional products.